Impact of Reducing Peginterferon Alfa-2a and Ribavirin Dose During Retreatment in Patients With Chronic Hepatitis C-Reference-Cited by-同舟云学术

Impact of Reducing Peginterferon Alfa-2a and Ribavirin Dose During Retreatment in Patients With Chronic Hepatitis C

Published:2007-01 Issue:1 Volume:132 Page:103-112
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Shiffman Mitchell L.,Ghany Marc G.,Morgan Timothy R.,Wright Elizabeth C.,Everson Gregory T.,Lindsay Karen L.,Lok Anna S.F.,Bonkovsky Herbert L.,Di Bisceglie Adrian M.,Lee William M.,Dienstag Jules L.,Gretch David R.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference23 articles.

1. Peginterferon-alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial;Manns;Lancet,2001

2. Combination of peginterferon alfa-2a (40 kD) plus ribavirin in patients with chronic hepatitis C virus infection;Fried;N Engl J Med,2002

3. Peginterferon-alfa 2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose;Hadziyannis;Ann Intern Med,2004

4. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C;McHutchison;Gastroenterology,2002

5. Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C;Davis;Hepatology,2003

Cited by 182 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of different anti-HCV regimens on platelet count during treatment in Egyptian patients;Egyptian Liver Journal;2020-09-01

2. NOD2 modulates immune tolerance via the GM-CSF–dependent generation of CD103+ dendritic cells;Proceedings of the National Academy of Sciences;2020-04-29

3. Bayesian Population Pharmacokinetic Modeling of Eltrombopag in Chronic Hepatitis C Patients;European Journal of Drug Metabolism and Pharmacokinetics;2018-06-14

4. Predictors of Severe Thrombocytopenia Secondary to Peginterferon Alfa-2a Treatment in Subjects With Hepatitis C Virus Infection;American Journal of Therapeutics;2017-11

5. Identification of novel inhibitors of HCV NS3 protease genotype 3 subtype B through molecular docking studies of phytochemicals from Boerhavia diffusa L;Medicinal Chemistry Research;2016-11-22